Health Care ETFs: Elixir for Your Portfolio
With a 4.3% increase during February, the cost of medical care in the U.S. continues to increase at nearly double the 2.4% pace of overall prices. So, it's no surprise that exchange-traded funds are being launched to invest in the companies benefiting from this pricing power.
On March 12, XShares Advisors introduced one composite and eight new sub-industry-specific health care funds. These were added to the five HealthShares ETFs that have been in the XShares product portfolio since Jan. 23.
With the addition of these 14 health and biotech related ETFs, there are now 37 funds covering this sector. No other specific sector has as many ETFs.
Let's say you are reading a scientific journal about breakthroughs with promising new cancer drugs, and you decide to invest in a biotech company that specializes in cancer drugs. Instead of betting the house on a single company, you can now buy the HealthShares Cancer ETF (HHK). This fund is comprised of 64.9% pharmaceutical stocks and 35.1% biotechnology stocks. By making one investment in 22 companies actively seeking novel cancer treatments, the odds of holding the one stock that hits it big are increased.Of course, the opposite can also true. Biotechnology and pharmaceutical stocks tend to be highly volatile, as potential new drugs succeed or fail at each stage of their clinical trials. So, if a proposed drug disappoints in trials or an existing drug is pulled from the market due to unacceptable side effects, expect to participate in the loss. If your other investments are causing anxiety, depression and loss of sleep, or you are just plain absent-minded, the HealthShares Neuroscience ETF (HHN) holds the companies that want to bring help.
|New XShares Advisors Funds|
|HealthShares Autoimmune-Inflammation ETF||HHA||3/12/2007|
|HealthShares Cancer ETF||HHK||3/12/2007|
|HealthShares Cardiology ETF||HRD||3/12/2007|
|HealthShares Composite ETF||HHQ||3/12/2007|
|HealthShares GI/Gender Health ETF||HHU||3/12/2007|
|HealthShares Metabolic-Endocrine Disorders ETF||HHM||3/12/2007|
|HealthShares Neuroscience ETF||HHN||3/12/2007|
|HealthShares Ophthamology ETF||HHZ||3/12/2007|
|HealthShares Respitory/Pulmonary ETF||HHR||3/12/2007|
|HealthShares Cardiology Devices ETF||HHE||1/23/2007|
|HealthShares Diagnostic ETF||HHD||1/23/2007|
|HealthShares Emerging Cancer ETF||HHJ||1/23/2007|
|HealthShares Enabling Technology ETF||HHV||1/23/2007|
|HealthShares Patient Care Services ETF||HHB||1/23/2007|
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV